Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Germana, Bancone"'
Autor:
François Nosten, Rose McGready, Mary Ellen Gilder, Borimas Hanboonkunupakarn, Verena Ilona Carrara, Germana Bancone, Elsie Win, Gornpan Gornsawun, Paw Khu Moo, Laypaw Archasuksan, Nan San Wai, Sylverine Win
Publikováno v:
BMJ Paediatrics Open, Vol 8, Iss 1 (2024)
Background Neonatal hyperbilirubinaemia (NH) is a common problem worldwide and is a cause of morbidity and mortality especially in low-resource settings.Methods A study was carried out at Shoklo Malaria Research Unit (SMRU) clinics along the Thailand
Externí odkaz:
https://doaj.org/article/3aaeb41669e74427869385b23f77c366
Autor:
Sasithon Pukrittayakamee, Podjanee Jittamala, James A Watson, Borimas Hanboonkunupakarn, Pawanrat Leungsinsiri, Kittiyod Poovorawan, Kesinee Chotivanich, Germana Bancone, Cindy S Chu, Mallika Imwong, Nicholas PJ Day, Walter RJ Taylor, Nicholas J White
Publikováno v:
eLife, Vol 12 (2024)
Background: Primaquine is an 8-aminoquinoline antimalarial. It is the only widely available treatment to prevent relapses of Plasmodium vivax malaria. The 8-aminoquinolines cause dose-dependent haemolysis in glucose-6-phosphate dehydrogenase deficien
Externí odkaz:
https://doaj.org/article/e585cfc833ba4c7cb5854b2dab312fc7
Autor:
Germana Bancone, Mary Ellen Gilder, Day Day Poe, Gornpan Gornsawun, Laypaw Archasuksan, Phyu Phyu Htway, Francois Nosten, Kesinee Chotivanich, Rose McGready
Publikováno v:
Wellcome Open Research, Vol 7 (2024)
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency represents a barrier to the full deployment of anti-malarial drugs for vivax malaria elimination and of first-line antibiotics. Lack of established reference ranges for G6PD activity in b
Externí odkaz:
https://doaj.org/article/6ed19dde36954f8ea2bb8c426a6d8f62
Autor:
Wondimagegn Adissu, Marcelo Brito, Eduardo Garbin, Marcela Macedo, Wuelton Monteiro, Sandip Kumar Mukherjee, Jane Myburg, Mohammad Shafiul Alam, Germana Bancone, Pooja Bansil, Sampa Pal, Abhijit Sharma, Stephanie Zobrist, Andrew Bryan, Cindy S Chu, Santasabuj Das, Gonzalo J Domingo, Amanda Hann, James Kublin, Marcus V G Lacerda, Mark Layton, Benedikt Ley, Sean C Murphy, Francois Nosten, Dhélio Pereira, Ric N Price, Arunansu Talukdar, Daniel Yilma, Emily Gerth-Guyette
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 10, p e0011652 (2023)
IntroductionScreening for G6PD deficiency can inform disease management including malaria. Treatment with the antimalarial drugs primaquine and tafenoquine can be guided by point-of-care testing for G6PD deficiency.Methods and findingsData from simil
Externí odkaz:
https://doaj.org/article/6046749186634df9825ceec3ba9bb654
Autor:
Walter R J Taylor, Niamh Meagher, Benedikt Ley, Kamala Thriemer, Germana Bancone, Ari Satyagraha, Ashenafi Assefa, Krisin Chand, Nguyen Hoang Chau, Mehul Dhorda, Tamiru S Degaga, Lenny L Ekawati, Asrat Hailu, Mohammad Anwar Hasanzai, Mohammad Nader Naddim, Ayodhia Pitaloka Pasaribu, Awab Ghulam Rahim, Inge Sutanto, Ngo Viet Thanh, Nguyen Thi Tuyet-Trinh, Naomi Waithira, Adugna Woyessa, Arjen Dondorp, Lorenz von Seidlein, Julie A Simpson, Nicholas J White, J Kevin Baird, Nicholas P Day, Ric N Price
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 9, p e0011522 (2023)
BackgroundThe World Health Organization recommends that primaquine should be given once weekly for 8-weeks to patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase (G6PD) deficiency, but data on its antirelapse efficacy and saf
Externí odkaz:
https://doaj.org/article/78102e14bb3e47dbbf049aebb8955204
Autor:
Kasia Stepniewska, Elizabeth N. Allen, Georgina S. Humphreys, Eugenie Poirot, Elaine Craig, Kalynn Kennon, Daniel Yilma, Teun Bousema, Philippe J. Guerin, Nicholas J. White, Ric N. Price, Jaishree Raman, Andreas Martensson, Richard O. Mwaiswelo, Germana Bancone, Guido J. H. Bastiaens, Anders Bjorkman, Joelle M. Brown, Umberto D’Alessandro, Alassane A. Dicko, Badria El-Sayed, Salah-Eldin Elzaki, Alice C. Eziefula, Bronner P. Gonçalves, Muzamil Mahdi Abdel Hamid, Akira Kaneko, Simon Kariuki, Wasif Khan, Titus K. Kwambai, Benedikt Ley, Billy E. Ngasala, Francois Nosten, Joseph Okebe, Aaron M. Samuels, Menno R. Smit, Will J. R. Stone, Inge Sutanto, Feiko Ter Kuile, Roger C. Tine, Alfred B. Tiono, Chris J. Drakeley, Roly Gosling, Andy Stergachis, Karen I. Barnes, Ingrid Chen
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-19 (2022)
Abstract Background In 2012, the World Health Organization (WHO) recommended single low-dose (SLD, 0.25 mg/kg) primaquine to be added as a Plasmodium (P.) falciparum gametocytocide to artemisinin-based combination therapy (ACT) without glucose-6-phos
Externí odkaz:
https://doaj.org/article/af68379be63845f6835e0350f9fff0b3
Autor:
Makoto Saito, Verena I. Carrara, Mary Ellen Gilder, Aung Myat Min, Nay Win Tun, Mupawjay Pimanpanarak, Jacher Viladpai-nguen, Moo Kho Paw, Warat Haohankhunnatham, Kamonchanok Konghahong, Aung Pyae Phyo, Cindy Chu, Claudia Turner, Sue J. Lee, Jureeporn Duanguppama, Mallika Imwong, Germana Bancone, Stephane Proux, Pratap Singhasivanon, Nicholas J. White, François Nosten, Rose McGready
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-14 (2021)
Abstract Background Artemisinin and artemisinin-based combination therapy (ACT) partner drug resistance in Plasmodium falciparum have spread across the Greater Mekong Subregion compromising antimalarial treatment. The current 3-day artemether-lumefan
Externí odkaz:
https://doaj.org/article/f77d7008b7a54ae0ba0f8ff6b54893f1
Autor:
Baburam Marasini, Bibek Kumar Lal, Suman Thapa, Kiran Raj Awasthi, Bijay Bajracharya, Pratik Khanal, Sanjeev Neupane, Shambhu Nath Jha, Sanjaya Acharya, Smriti Iama, Madan Koirala, Dinesh Koirala, Suresh Bhandari, Ram Kumar Mahato, Arun Chaudhary, Pramin Ghimire, Rahachan Gharti Magar, Rajan Kumar Bhattarai, Gornpan Gornsawun, Pimsupah Penpitchaporn, Germana Bancone, Bhim Prasad Acharya
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-9 (2020)
Abstract Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. The World Health Organization (WHO) recommends G6PD scree
Externí odkaz:
https://doaj.org/article/a9d536b273974e9ba272261206e78911
Autor:
Tobias Brummaier, Mary Ellen Gilder, Gornpan Gornsawun, Cindy S. Chu, Germana Bancone, Mupawjay Pimanpanarak, Kesinee Chotivanich, François Nosten, Rose McGready
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-7 (2020)
Abstract Background The Sustainable Development Goals (SDG) call for increased gender equity and reduction in malaria-related mortality and morbidity. Plasmodium vivax infections in pregnancy are associated with maternal anaemia and increased adverse
Externí odkaz:
https://doaj.org/article/dc06c68a995046329dc5ff6fd2318a0e
Autor:
Benedikt Ley, Ari Winasti Satyagraha, Mohammad Golam Kibria, Jillian Armstrong, Germana Bancone, Amy K. Bei, Greg Bizilj, Marcelo Brito, Xavier C. Ding, Gonzalo J. Domingo, Michael E. von Fricken, Gornpan Gornsawun, Brandon Lam, Didier Menard, Wuelton Monteiro, Stefano Ongarello, Sampa Pal, Lydia Visita Panggalo, Sunil Parikh, Daniel A. Pfeffer, Ric N. Price, Alessandra da Silva Orfano, Martina Wade, Mariusz Wojnarski, Kuntawunginn Worachet, Aqsa Yar, Mohammad Shafiul Alam, Rosalind E. Howes
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 2 (2022)
Background The introduction of novel short course treatment regimens for the radical cure of Plasmodium vivax requires reliable point-of-care diagnosis that can identify glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. While deficient
Externí odkaz:
https://doaj.org/article/642a94882b9840718bf43f3aab3c7603